Award and Tables Hosts
Abingworth | Jefferies |
Albion Ventures | Karus Therapeutics |
Apollo Investment Committee | Kesios Therapeutics |
Astrazeneca | Klein-Edmonds Associates |
Bloomberg Intelligence | Lilly |
Biopharm Insight | Mereo Biopharma |
Biotech and Money | Midatech Pharma |
C4X Discovery | MISSION Therapeutics |
Cambridge Enterprise | Modern Biosciences |
Cancer Research Technology | NetScientific |
Chronos Therapeutics | NightstaRx |
Clinigen | Novabiotics |
CMS Cameron McKenna | Novasecta |
Coulter Partenrs | NP Investments |
Covington & Burling | Numis Securities |
Crescendo Biologics | Orchard Therapeutics |
Domainex | Oxford University Innovation |
Drugs & Dealers Magazine | Peptinnovate |
EY | ProAxsis |
F2G | Promentra |
F-Star Biotechnology | Psioxus Therapeutics |
finnCap | Puridify |
FTI Consulting | RBC Capital Markets |
GHO Capital | Redx Pharma |
Gill Jennings & Every | Sanofi |
GSK | SV Life Sciences |
Helomics | Syndicate Room |
Horizon Discovery | Trinity Delta |
Hume Brophy | UCL Business |
Immunocore | Verona Pharma |
Imperial Innovations | White & Case |
Instinctif Partners |
© 2016 All Rights Reserved By Biotech and Money